Antibody-dependent cell-mediated cytotoxicity- and complement-dependent cytotoxicity-independent bactericidal activity of an IgG against Pseudomonas aeruginosa O6ad.
In addition to Ag recognition, some Abs are capable of killing target organisms in the absence of phagocytes and complement. In this study, we report that an anti-Pseudomonas aeruginosa O6ad LPS IgG(1), tobacco-expressed human S20 IgG(1) (te-hS20), as well as its recombinant Fab and single-chain variable fragment (scFv) fragments have cellular- and complement-independent bactericidal activity. te-hS20 and its Fab and scFv significantly reduced viability of P. aeruginosa O6ad in dose- and time-dependent manners in vitro and also showed lower levels of bactericidal activity against P. aeruginosa PAO1, but had no activity against P. aeruginosa O10, Escherichia coli TG1, and Streptococcus agalactiae. The H chain and its Fd fragment both had significant Ag-binding and bactericidal activities against P. aeruginosa O6ad. Bactericidal activity was completely inhibited with specific LPS Ag, suggesting that Ag binding is involved in the bactericidal mechanism. Live/dead cell staining and electron microscopic observations indicate that the bactericidal effect was due to disruption of the cell wall and suggest inhibition of cell division. In addition to te-hS20, the Fab and scFv were also protective in vivo, as leukopenic mice had prolonged and improved survival after administration of these Ab fragments followed by challenge with P. aeruginosa O6ad cells at 80-90% lethal dose, supporting a bactericidal mechanism independent of phagocytes and complement. Understanding of the bactericidal mechanism will allow assessment of the potential for therapeutic application of these Abs.
Xie
Xuemei
X
School of Environmental Sciences, University of Guelph, Guelph, Ontario, Canada.
McLean
Michael D
MD
Hall
J Christopher
JC
D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology*; D000920:Antibody-Dependent Cell Cytotoxicity / Q000276:immunology*; D003167:Complement Activation / Q000276:immunology*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology*; D008222:Lymphokines / Q000276:immunology; D051379:Mice; D008855:Microscopy, Electron, Scanning; D030821:Plants, Genetically Modified; D011550:Pseudomonas aeruginosa / Q000276:immunology* / Q000648:ultrastructure; D012795:Sialoglycoproteins / Q000276:immunology; D014026:Nicotiana / Q000235:genetics
D000907:Antibodies, Bacterial; C089422:Fv protein, human; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D008222:Lymphokines; D012795:Sialoglycoproteins